Login
Navigate Fool.com
Will PRAN beat
the market?
Community Rating: 2 Stars: Unattractive

1.89 0.15 (8.62%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $1.73
Previous Close $1.74
Daily Range $1.73 - $1.90
52-Week Range $1.67 - $13.29
Market Cap $78.7M
P/E Ratio -13.50
Dividend (Yield) $0.00 (0.0%)
Volume 1,245,997
Average Daily Volume 2,859,812
Current FY EPS $0.00

How do you think PRAN
will perform against the market?

Top PRAN Bull/Bear Pitches

 

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches here!

 

zzlangerhans (< 20)
Submitted September 19, 2011

Today's events provide further evidence that the management of Prana is desperate and unprincipled. The stock was up as high as 2.25 near the open after the company issued a PR titled &quot;Prana‚Äôs PB … More

0 Replies Reply Report this Post

News & Commentary

The Worst Biotech Failures of the Week

See which companies suffered the worst clinical setbacks in the week ending April 4.

This Week in Biotech: Data Disappointments Come in Threes

Three clinical data disappointments, one biotech's wild ride, and a global biopharma's oncology data deluge highlight this week's top biotech stories.

Investor Beat: The End of the First Quarter -- How Did We Do?

As Q1 comes to a close, here's how it all shook out for investors. Plus, four stocks making big moves on Monday's market, and why our analysts are watching Microsoft and CBS Outdoor today.

Big Movers Today: Panera, Delta, GM, and Prana Biotechnology

Panera gets an upgrade, and Delta partners with Virgin Atlantic. Here are four stocks making big moves on Monday's market.

Down 70%: Is Prana Biotechnology Ltd. a Buy?

Shares of Prana were absolutely crushed today, after a phase 2 failure for its Alzheimer's drug.

Why Prana Biotechnology Limited Got Pummeled

Is this meaningful or just another movement?

U.S. stocks rise; Dow in triple digit gain

US Futures Gain At Quarter-End Before Yellen Speaks; J&J Takes $4 Bln Bid For Ortho-Clinical Unit

J&J sells Ortho-Clinical Diagnostics; Prana falls

Sector Update: Healthcare Shares Flat in Pre-Market; Novartis Rallies 4% on Conclusion of Chronic He

Sector Update: Healthcare Shares Flat in Pre-Market; Novartis Rallies 4% on Conclusion of Chronic Heart Failure Treatment Study

See More PRAN News...

Sector

Healthcare

Industry

Drugs

Prana Biotechnology Limited (ADR) (PRAN) Description

The Company develops therapeutic drugs designed to treat the underlying causes of degeneration of the brain and the eye as the aging process progresses, initially focusing on Alzheimer's disease. Website: http://www.pranabio.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks